Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,401 total articles
Actuate Therapeutics announced that its clinical-stage drug elraglusib will be evaluated in the landmark European BEACON2 multi-arm, multi-stage Phase 1/2 trial for children with relapsed and refractory neuroblastoma. Elraglusib will be assessed in combination with dinutuximab beta and chemotherapy to determine safety and optimal dosing. The trial …
ZenaTech, a company specializing in AI-driven drone platforms and enterprise SaaS solutions, has been added to the Russell 3000® Index effective June 29, 2026. This milestone reflects the company's expanding market capitalization and growth, expected to increase visibility among institutional investors and bolster investor confidence in its AI dron…
BitFuFu Inc. announced its May 2026 Bitcoin production and operational results, highlighting a 22.1% month-over-month increase in Bitcoin production to 177 BTC. The company significantly shifted its production mix by nearly tripling self-mining output to 90 BTC, reflecting a strategic decision to accumulate Bitcoin holdings amid favorable market co…
PureCycle Technologies announced the successful production and trial evaluation of white, cavitated biaxially oriented polypropylene (BOPP) film using its PureFive Choice™ recycled polypropylene resin, in partnership with Innovia Films. This film contains more than 40% post-consumer recycled content and meets performance and appearance standards im…
Applied Materials announced a quarterly cash dividend of $0.53 per share payable on September 10, 2026, continuing its pattern of dividend growth with nine consecutive years of increases. The company has increased dividends at an 18% compound annual growth rate over the past decade and distributed a significant portion of free cash flow to sharehol…
BrainsWay Ltd. presented new 12-month durability data demonstrating that their FDA-cleared SWIFT™ accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) protocol provides sustained remission in over 80% of Major Depressive Disorder patients, significantly improving functionality and quality of life with fewer clinic visits compared to standa…
Creative Realities, Inc. announced its inclusion in the Russell 3000 Index effective June 29, 2026, reflecting its growing market capitalization and integration of Cineplex Digital Media. This inclusion is expected to broaden its institutional investor base and affirm its growth strategy in digital signage and AdTech sectors.
CVRx, Inc., a NASDAQ-listed medical device company specializing in neuromodulation solutions for cardiovascular diseases, announced that CFO Jared Oasheim will step down to pursue other opportunities but will stay until a successor is appointed and remain an advisor through February 2027. Oasheim has been with the company since 2015 and helped lead…
FTI Consulting has appointed Sean O'Reilly, a seasoned healthcare executive with over 25 years of experience in compliance and regulatory risk management, as Senior Managing Director in its Healthcare Risk Management & Advisory practice. O'Reilly will leverage advanced analytics and AI to enhance clients' enterprise compliance programs, focusing on…
FitLife Brands, Inc. announced a new marketing partnership with renowned competitive eater Joey Chestnut to promote its Dr. Tobias Colon 14 Day Cleanse supplement. The 'Cleanse Like a Winner' campaign aims to connect wellness and digestive health with a champion mindset and leverages social media platforms to inspire consumers towards consistent he…
TG Therapeutics announced positive topline Phase 1 results for subcutaneous BRIUMVI (ublituximab-xiiy) in patients with myasthenia gravis (MG), showing significant clinical improvement and good tolerability. The company also initiated a potentially registration-directed Phase 2 trial to evaluate BRIUMVI as maintenance therapy following induction wi…
Corvus Pharmaceuticals announced a $5 million investment as part of a $13.5 million financing round for its collaboration partner Angel Pharmaceuticals. The funding will support ongoing and upcoming Phase 1b/2 clinical trials of soquelitinib for atopic dermatitis and asthma in China. Corvus retains a significant ownership stake in Angel Pharma and …
QTREX Quantum Ltd. announced receiving approximately $1 million from the Israel Innovation Authority to develop a specialized dielectric material optimized for high-density, low-loss RF signal routing in superconducting quantum computers. This development aims to overcome the key scaling challenges in quantum hardware connectivity by integrating ma…
SCHMID Group N.V. has signed a preliminary agreement with local Chinese authorities to establish a new manufacturing campus in Zhongshan, Guangdong Province. The new facility will consolidate existing operations, nearly doubling manufacturing capacity to support increased demand for advanced electronics manufacturing equipment in China. The €11 mil…
Alterity Therapeutics announced successful alignment with the U.S. FDA during the End-of-Phase 2 meeting, agreeing on key aspects of the planned Phase 3 clinical trial for ATH434 in treating Multiple System Atrophy (MSA). The FDA approved the study population, dosing regimen, treatment duration, primary and key secondary endpoints, and statistical …
Ridgepost Capital appoints Brian McKenna as Vice President of Investor Relations to enhance communication with institutional investors and lead the firm's investor relations strategy. McKenna brings over a decade of experience in equity research and alternative asset management, supporting Ridgepost Capital's growth ambitions in private markets.
SailPoint, Inc., a leader in enterprise identity security, announced its financial results for the fiscal first quarter ended April 30, 2026. The company provided access to its earnings release, presentation, and scheduled a conference call to discuss the results and outlook.
Cartesian Therapeutics has announced a strategic licensing agreement with WestGene Biopharma to combine Cartesian's mRNA CAR-T payload technology with WestGene's targeted lipid nanoparticle platform for in vivo delivery. The partnership aims to initiate Phase 1 clinical trials in the second half of 2026 for generalized myasthenia gravis patients, w…
Kymera Therapeutics announced the dosing of the first participant in the Phase 1 trial of KT-485, an oral IRAK4 degrader for immuno-inflammatory diseases, conducted by partner Sanofi. This milestone triggered a $20 million payment from Sanofi to Kymera under their collaboration, which includes potential total milestones of up to $975 million. The t…
CECO Environmental Corp. has provided a positive post-closing update on its recent acquisition of Thermon Group Holdings, reporting that integration is on track and yielding immediate benefits. The company raised its full-year 2026 guidance, expecting a 20% revenue increase and 25% growth in Adjusted EBITDA, reflecting strong market demand and anti…
Village Farms International, Inc. has commenced cultivation at its fully operational Phase II facility in Groningen, Netherlands, following regulatory approval. This expansion is expected to ramp up to full production capacity by early 2027, increasing the company's annualized production capacity in the Netherlands to approximately 10 metric tonnes…
DBV Technologies announced that while its management will participate in one-on-one investor meetings at the Goldman Sachs 47th Annual Global Healthcare Conference, CEO Daniel Tassé will not attend the previously scheduled fireside chat due to travel disruptions. The company focuses on developing epicutaneous immunotherapy treatments for food aller…
Aclarion, a healthcare technology company, has partnered with PRIA Healthcare to launch a Market Access Program aimed at advancing reimbursement and commercial adoption of its AI-driven Nociscan platform for chronic low back pain. Building on successful payer approvals in the UK, this initiative seeks to streamline U.S. reimbursement processes and …
17 Education & Technology Group Inc., a leading Chinese education technology company listed on NASDAQ, will release its unaudited first quarter 2026 financial results on June 16, 2026, followed by a management conference call. The company specializes in data-driven teaching and learning solutions and SaaS products to facilitate digital transformati…
Fury Gold Mines Limited has initiated the pre-feasibility study phase for its Eau Claire gold project in northern Quebec by retaining top technical consultants SGS Geological Services and BBA Consultants. This marks a significant development step following the 2025 preliminary economic assessment, aiming to provide clearer insights into the project…
